Deutscher Krebshilfe Preis 2025

22/04/2025 | News

German Cancer Award 2025 for Matthias Fischer

 

We are excited to announce that our Principal Investigator Prof. Dr. Matthias Fischer (Head of Experimental Pediatric Oncology at the University Hospital of Cologne) has been awarded the German Cancer Prize 2025 in the "Experimental Research" category for his outstanding scientific achievements in neuroblastoma research.

Press release:
medfak.uni-koeln.de/en/news-details/prof-matthias-fischer-erhaelt-deutschen-krebspreis-2025

 

Back
SFB 1399 Mechanisms of Drug Sensitivity and Resistance in Small Cell Lung Cancer

SFB 1399 Mechanisms of Drug Sensitivity
and Resistance in Small Cell Lung Cancer

c/o Department of Translational Genomics
University of Cologne
Weyertal 115b
50931 Cologne, Germany

+49-221-478-98777
info[@]sfb1399.de

Imprint
Privacy Policy

Partners:

University of Cologne University Hospital of Cologne University Hospital Essen Max Planck Institute for Metabolism Research TRON – Translational Oncology at the University Medical Center of the Johannes Gutenberg University Main University of Bonn University of Frankfurt Deutsche Forschungsgemeinschaft CIO Centrum für integrierte Onkologie Aachen Köln Bonn Düsseldorf Lung Cancer Group Cologne